PGI5 COSTS BENEFITS WITH ESOMEPRAZOLE 20MG 'ONDEMAND' TREATMENT IN GASTROESOPHAGEAL REFLUX DISEASE (GERD) PATIENTS IN BELGIUM
Nov 1, 2004, 00:00 AM
10.1016/S1098-3015(10)66008-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)66008-1/fulltext
Section Title :
Section Order :
375
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66008-1&doi=10.1016/S1098-3015(10)66008-1